Address And Details

82 Devonshire St , Boston, MA 02109
Fund Manager Matthew Fruhan
Manager Tenure 16 Years 4 Months

Strategy And Objective

The fund seeks long-term growth of capital.Normally investing at least 80% of assets in common stocks of companies with large market capitalizations (which, for purposes of this fund,are those companies with market capitalizations similar to companies in the Russell 1000 Index or the S&P 500 Index).Investing in domestic and foreign issuers.Investing in either "growth" stocks or "value" stocks or both.Using fundamental analysis of factors such as each issuer's financial condition and industry position,as well as market and economic conditions,to select investments.

Net Asset Value

as of 5:12 PM ET 09/24/2021

Performance

  • 1 Week
  • +1.40%
  • 1 Month
  • -0.65%
  • 3 Months
  • +0.24%
  • 1 Yr Return
  • +41.17%
  • 5 Yr Return
  • +48.67%

Equity Sector Breakdown

Technology 23.49%
Finance 22.48%
IndustrialCyclical 14.98%
NonDurables 10.10%
Energy 7.25%
Health 6.38%
RetailTrade 5.27%
ConsumerDurables 2.73%
Services 1.22%
Utilities 0.35%

Asset Allocation

Asset Type % Of Allocation
Stocks 98.77%
ForeignStocks 9.19%
Preferred 0.09%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 3.03 B

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -4.81 -3.66 -2.54
Beta 1.09 1.09 1.11
R Squared 0.91 0.90 0.91
Std Deviation 21.18 17.19 15.55
Sharpe Ratio 0.71 0.90 n/a

Purchase Information

as of 5:21 PM ET 09/23/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +38.92%
  • +48.94%
+38.92% +48.94%
3 Year
  • +13.66%
  • +15.65%
+13.66% +15.65%
10 Year
  • +14.96%
  • +13.83%
+14.96% +13.83%
Life Of Fund
  • +9.44%
  • +9.46%
+9.44% +9.46%

Top 10 Holdings

Symbol Company Name % Of Assets
GE GENERAL ELECTRIC CO 6.79%
MSFT MICROSOFT CORP 6.01%
WFC WELLS FARGO & CO 4.61%
XOM EXXON MOBIL CORP 4.16%
BAC BANK OF AMERICA CORPORATION 3.70%
CMCSA COMCAST CORP 3.42%
AAPL APPLE INC 3.01%
MO ALTRIA GROUP INC 2.71%
UPS UNITED PARCEL SERVICE 2.16%
QCOM QUALCOMM INC 1.94%

LATEST NEWS

Recent Articles from TheStreet

Nikola

Tim Collins on How to Trade Nikola

Technical setups and short interest make much hated name volatile, and therefore interesting.

Chinese Firms Should Face Faster US Stock Delisting Over Audit Rules, SEC Chairman Gary Gensler Tells Lawmakers

Jim Cramer: Gensler's Plate is Very Full

SEC Chairman is key player in efforts to rein in ceaseless financial engineering.

stocks rise asset management sh

Cramer's Mad Money Recap: Advanced Micro Devices, Nvidia, Thor

Jim Cramer has your game plan for next week, which he says will be the calm before the earnings season storm.

Jim Cramer: Starbucks Needs More Traffic in Stores

Starbucks Resists Union Effort in New York Region: Report

Starbucks reportedly said it will raise wages and benefits and a union isn’t needed, to employees at three stores in Buffalo New York.

Exxon Mobil

Exxon, Occidental, Baker Hughes Make Goldman Turnaround List

Exxon has 'reduced costs, surprised to the downside on capital spending, outperformed our expectations in downstream/chemicals,' Goldman said.

videoblocks-a-series-of-fullhd-close-up-rotating-slider-dollymacro-shots-of-the-surface-of-computer-hardware-parts-chipsmotherboardcpucurcuits-close-up-macro-computer-chips-circuits-surface-rotating-dolly_s_mt0i43g_1080__D

Jim Cramer is Tired of the Weak Response to Chip Shortages

Companies need to forget about help from Washington and step up to the plate.

Microsoft Lead

Why 'Sarge' Guilfoyle Isn't Selling His Microsoft

Sharp management and strength across its business lines are keys to software giant.

Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer

Bret Jensen: Paratek Deal Shows Promise

While antibiotics are usually less profitable and slower to develop market share than other drugs, Paratek has a key factor in its favor.

Stocks Close Higher as Wall Street Dissects New Tax Laws

Stocks End Mixed Amid Evergrande Default Saga, Supply Chain Chaos

Evergrande's default saga, as well as mounting supply chain issues, have stocks trading mixed Friday.

bitcoin copy

Stock Market Today With Jim Cramer: China's Crypto Clampdown

Jim Cramer discusses China's crypto clampdown and Nike's report.